期刊文献+

^(103)Pd放射性支架植入犬胆管的可行性及安全性实验研究

The feasibility and safety of implantation of ^(103)Pd radioactive mental stent in canine bile duct
下载PDF
导出
摘要 目的观察动物胆管植入103Pd放射性支架后胆管腔内照射的放射性损伤。方法实验动物为雄性健康Beagle犬,体重9 ̄11kg。麻醉下经手术植入103Pd放射性金属支架于犬的胆管腔内,支架放射性活度分别为0、3.5、5.5、7.5、10mCi,植入30d后取出金属支架和胆管,胆管经组织切片HE染色,光镜下评价胆管放射性损伤,同时监测肝肾功能、血淀粉酶。结果放射性活度为3.5mCi时光镜下可观察到胆管黏膜损伤;放射性活度为7.5mCi时胆管放射性损伤达肌层;放射性活度为10mCi时未出现胆管穿孔。放射性支架对于周围脏器无损伤,安全性高。结论103Pd放射性支架胆管腔内近距离照射有明显的量效关系,为应用于临床治疗胆管恶性肿瘤提供了实验依据。 Objective To evaluate the feasibility and safety of implantation of 103Pd radioactive mental stent in canine bile duct. Methods Beagle dogs with body weight of 9 to 1 lkg were used, the 103Pd stent was implanted into the common bile duct under anesthesia, and the irradiation doses were 0mCi, 3.5mCi, 5.5mCi, 7.5mCi, 10mCi respectively. Results Radiation injury on the mucosa of the bile duct was observed in 3.5mCi group, the injury extended to the muscular layer was observed in 7.5mCi group. There was no perforation observed up to radioactive dose of 10mCi, and there was no radioactive injury observed in the surrounding organs either. Conclusion There is an dose-response relationship for 103Pd radioactive mental stent implanted in canine bile duct.
出处 《浙江医学》 CAS 2007年第12期1271-1272,1290,共3页 Zhejiang Medical Journal
关键词 放射性支架 胆管 103Pd Radioactive stent Bile duct 103Pd
  • 相关文献

参考文献3

二级参考文献19

  • 1Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regiment after coronary artery stenting. Stent Anticoagulation Restonosis Study Investigators. N Engl J Med, 1998,339:1665-1671.
  • 2Zimarino M, Weissman N J, Waksman R, et al. Analysis of stent edge restenosis with different forms of brachytherapy. Am J Cardi, 2002,89:322-325.
  • 3Sabate M, Costa MA, Kozuma K, et al. Geographic miss: A cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation, 2000, 101:2467-2471.
  • 4Warden A J, Knook AHM, Kay IP, et al. Clinical and angiographical follow-up after implantation of a 6-12uCi radioactive stent in patients with coronary artery disease. Eur Heart J, 2001,22:669-675.
  • 5Warden A J, Albiero R, Kay IP, et al. Angiographical follow-up after radioactive“Cold Ends” stent implantation: a multicenter trial.Circularion, 2002,105:550-553.
  • 6Serruys PW, Kay IP. I like the candy, I hate the wrapper: the ^32P radioactive stent. Circulation, 2000,101:3-7.
  • 7Albiero R, Nishida T, Adamian M, et al. Edge restenosis after implantation of high activity ^32P radioactive beta-emitting stents.Circulation, 2000,101:2454-2457.
  • 8Nath R, Amols H, Coffey C, et al. Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 60. American Association of Physicists in Medicine, Med Phys,1999,26:119-152.
  • 9Meigooni AS, Sabinis A, Nath R. Dosimetry of ^103Pd brachytherapy sources for permanent implant. Endocurietherapy Hypeztherm. Oncol,1990,6:107-177.
  • 10Chiu ST, Anderson LL. Thennoluminiscent Dosimetry for ^103Pd(model) in solid water phantom. Med Phys, 1991,18:449-552.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部